InMode Ltd.

InMode Ltd. confirmed it received an unsolicited acquisition proposal from Steel Partners Holdings L.P. dated July 9, 2026. The company's Board of Directors has formed a Special Committee of independent directors to review the proposal with its advisors. Additionally, M.N. Business Strategy Ltd. extended the expiration date of its prior unsolicited proposal through September 15, 2026.

InMode Ltd. announced that Serendia LLC filed a patent infringement lawsuit against the company and its subsidiary, Invasix Inc., on June 22, 2026. The complaint, filed in the U.S. District Court for the Central District of California, alleges infringement of four U.S. patents by InMode's microneedling dermatological treatment devices, including its Morpheus8 products. Serendia is seeking unspecified damages and an injunction. A parallel complaint was also filed with the International Trade Commission. InMode plans to vigorously defend against the allegations.

InMode Ltd. confirmed receipt of an unsolicited proposal from M.N. Business Strategy, Ltd. to acquire all outstanding ordinary shares not already owned by the group for $16.20 per share in cash. M.N. Business Strategy includes the company's co-founder and CEO, Moshe Mizrahy. In response, InMode's Board of Directors has formed a special committee of independent directors to evaluate the proposal, with no assurance of a resulting transaction.

InMode Ltd. has issued a notice for its Annual General Meeting (AGM) to be held on July 30, 2026. Key agenda items include the re-election of Dr. Hadar Ron to the Board, the re-appointment of Kesselman & Kesselman (PwC) as independent auditors, the approval of Restricted Share Unit (RSU) grants to non-executive directors, and the approval of compensation terms for the Special Committee. The Board recommends shareholders vote in favor of all proposals. Shareholders of record as of June 26, 2026, are entitled to vote.

InMode Ltd. announced the immediate appointment of Dr. Shlomo Nass as Chairman of its Board of Directors and Moshik Itzkovich as Chief Financial Officer. Dr. Nass, with extensive experience in corporate law and governance, succeeds Dr. Michael Anghel. Moshik Itzkovich, previously Senior Vice President of Finance at InMode, takes over from Yair Malca, who will assist with the transition.

InMode reported Q1 2026 GAAP revenue of $82.0 million, a 5% increase year-over-year, meeting expectations despite a challenging macroeconomic environment. However, profitability was lower than expected, with GAAP net income decreasing to $11.6 million from $18.2 million in Q1 2025. The company also announced significant management changes, including the departure of CFO Yair Malca and Board Chairman Dr. Michael Anghel, with Dr. Hadar Ron appointed Interim Chair of the Board. InMode also completed $34.8 million in share repurchases during the quarter.